Cargando…
Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives
Airway remodeling is a frequent pathological feature of severe asthma leading to permanent airway obstruction in up to 50% of cases and to respiratory disability. Although structural changes related to airway remodeling are well-characterized, immunological processes triggering and maintaining this...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974749/ https://www.ncbi.nlm.nih.gov/pubmed/35386663 http://dx.doi.org/10.3389/falgy.2022.806391 |
_version_ | 1784680265747005440 |
---|---|
author | Margelidon-Cozzolino, Victor Tsicopoulos, Anne Chenivesse, Cécile de Nadai, Patricia |
author_facet | Margelidon-Cozzolino, Victor Tsicopoulos, Anne Chenivesse, Cécile de Nadai, Patricia |
author_sort | Margelidon-Cozzolino, Victor |
collection | PubMed |
description | Airway remodeling is a frequent pathological feature of severe asthma leading to permanent airway obstruction in up to 50% of cases and to respiratory disability. Although structural changes related to airway remodeling are well-characterized, immunological processes triggering and maintaining this phenomenon are still poorly understood. As a consequence, no biotherapy targeting cytokines are currently efficient to treat airway remodeling and only bronchial thermoplasty may have an effect on bronchial nerves and smooth muscles with uncertain clinical relevance. Th17 cytokines, including interleukin (IL)-17 and IL-22, play a role in neutrophilic inflammation in severe asthma and may be involved in airway remodeling. Indeed, IL-17 is increased in sputum from severe asthmatic patients, induces the expression of “profibrotic” cytokines by epithelial, endothelial cells and fibroblasts, and provokes human airway smooth muscle cell migration in in vitro studies. IL-22 is also increased in asthmatic samples, promotes myofibroblast differentiation, epithelial-mesenchymal transition and proliferation and migration of smooth muscle cells in vitro. Accordingly, we also found high levels of IL-17 and IL-22 in a mouse model of dog-allergen induced asthma characterized by a strong airway remodeling. Clinical trials found no effect of therapy targeting IL-17 in an unselected population of asthmatic patients but showed a potential benefit in a sub-population of patients exhibiting a high level of airway reversibility, suggesting a potential role on airway remodeling. Anti-IL-22 therapies have not been evaluated in asthma yet but were demonstrated efficient in severe atopic dermatitis including an effect on skin remodeling. In this review, we will address the role of Th17 cytokines in airway remodeling through data from in vitro, in vivo and translational studies, and examine the potential place of Th17-targeting therapies in the treatment of asthma with airway remodeling. |
format | Online Article Text |
id | pubmed-8974749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89747492022-04-05 Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives Margelidon-Cozzolino, Victor Tsicopoulos, Anne Chenivesse, Cécile de Nadai, Patricia Front Allergy Allergy Airway remodeling is a frequent pathological feature of severe asthma leading to permanent airway obstruction in up to 50% of cases and to respiratory disability. Although structural changes related to airway remodeling are well-characterized, immunological processes triggering and maintaining this phenomenon are still poorly understood. As a consequence, no biotherapy targeting cytokines are currently efficient to treat airway remodeling and only bronchial thermoplasty may have an effect on bronchial nerves and smooth muscles with uncertain clinical relevance. Th17 cytokines, including interleukin (IL)-17 and IL-22, play a role in neutrophilic inflammation in severe asthma and may be involved in airway remodeling. Indeed, IL-17 is increased in sputum from severe asthmatic patients, induces the expression of “profibrotic” cytokines by epithelial, endothelial cells and fibroblasts, and provokes human airway smooth muscle cell migration in in vitro studies. IL-22 is also increased in asthmatic samples, promotes myofibroblast differentiation, epithelial-mesenchymal transition and proliferation and migration of smooth muscle cells in vitro. Accordingly, we also found high levels of IL-17 and IL-22 in a mouse model of dog-allergen induced asthma characterized by a strong airway remodeling. Clinical trials found no effect of therapy targeting IL-17 in an unselected population of asthmatic patients but showed a potential benefit in a sub-population of patients exhibiting a high level of airway reversibility, suggesting a potential role on airway remodeling. Anti-IL-22 therapies have not been evaluated in asthma yet but were demonstrated efficient in severe atopic dermatitis including an effect on skin remodeling. In this review, we will address the role of Th17 cytokines in airway remodeling through data from in vitro, in vivo and translational studies, and examine the potential place of Th17-targeting therapies in the treatment of asthma with airway remodeling. Frontiers Media S.A. 2022-02-02 /pmc/articles/PMC8974749/ /pubmed/35386663 http://dx.doi.org/10.3389/falgy.2022.806391 Text en Copyright © 2022 Margelidon-Cozzolino, Tsicopoulos, Chenivesse and de Nadai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Allergy Margelidon-Cozzolino, Victor Tsicopoulos, Anne Chenivesse, Cécile de Nadai, Patricia Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives |
title | Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives |
title_full | Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives |
title_fullStr | Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives |
title_full_unstemmed | Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives |
title_short | Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives |
title_sort | role of th17 cytokines in airway remodeling in asthma and therapy perspectives |
topic | Allergy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974749/ https://www.ncbi.nlm.nih.gov/pubmed/35386663 http://dx.doi.org/10.3389/falgy.2022.806391 |
work_keys_str_mv | AT margelidoncozzolinovictor roleofth17cytokinesinairwayremodelinginasthmaandtherapyperspectives AT tsicopoulosanne roleofth17cytokinesinairwayremodelinginasthmaandtherapyperspectives AT chenivessececile roleofth17cytokinesinairwayremodelinginasthmaandtherapyperspectives AT denadaipatricia roleofth17cytokinesinairwayremodelinginasthmaandtherapyperspectives |